|
2018 Conference Publication Escape form adaptive drug tolerance through OGT and TET1 mediated H3K4me3 remodeling in MAPKi-resistant melanomaMenon, D. Ravindran, Hammerlindl, H., Emran, A., Torrano, J., Hammerlindl, S., Zhang, G., Krause, L., Somasundaram, R., Sturm, R., Haass, N. K., Flaherty, K., Herlyn, M. and Schaider, H. (2018). Escape form adaptive drug tolerance through OGT and TET1 mediated H3K4me3 remodeling in MAPKi-resistant melanoma. International Investigative Dermatology (IID) Meeting, Orlando, Fl, United States, 16-19 May 2018. London, United Kingdom: Nature Publishing Group. doi: 10.1016/j.jid.2018.03.1252 |
|
2018 Conference Publication Magnolol induces cell death through PI3K/Akt mediated epigenetic modifications boosting targeted inhibition in BRAF and NRAS mutant melanomaEmran, A., Chowdhury, B. R., Hammerlindl, H., Ahmed, F., Haass, N. K., Schuehly, W. and Schaider, H. (2018). Magnolol induces cell death through PI3K/Akt mediated epigenetic modifications boosting targeted inhibition in BRAF and NRAS mutant melanoma. Australasian College of Dermatologists, 51st Annual Scientific Meeting, Gold Coast, QLD, Australia, 19-22 May 2018. Hoboken, NJ, United States: Wiley. |
|
2018 Conference Publication Distinct expression profiles of chemokine- and nuclear orphan receptors in the development and early progression of follicular lymphomaSchukoff, T., Winkler, S., Unterluggauer, J. J., Fechter, K., Greinix, H., Beham-Schmid, C., Schaider, H., Deutsch, A., Prochazka, K. and Neumeister, P. (2018). Distinct expression profiles of chemokine- and nuclear orphan receptors in the development and early progression of follicular lymphoma. Deutscher Krebskongress, Berlin, Germany, 21-24 February 2018. Basel, Switzerland: S. Karger. |
|
2017 Conference Publication Human lactoferricin derived peptides trigger apoptosis in malignant melanoma in vitro and in vivoRiedl, S., Rinner, B., Schaider, H., Liegl-Atzwanger, B., Wodlej, C., Lohner, K. and Zweytick, D. (2017). Human lactoferricin derived peptides trigger apoptosis in malignant melanoma in vitro and in vivo. 19th IUPAB Congress / 11th EBSA Congress, Edinburgh Scotland, 16-20 July 2017. New York, NY, United States: Springer. |
|
2017 Conference Publication Involution of selective melanocytic lesions in a 79 year-old male with metastatic melanoma on immunotherapyThomas, S., Schaider, H., Laino, A., Adams, L. and Soyer, P. (2017). Involution of selective melanocytic lesions in a 79 year-old male with metastatic melanoma on immunotherapy. Australasian College of Dermatologists 50th Annual Scientific Meeting, Darling Harbour, New South Wales, Australia, 6–9 May 2017. Richmond, VIC., Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/ajd.21_12652 |
|
2016 Conference Publication Rose Bengal melanoma therapy - phototoxicity versus intrinsic cytotoxicityNierfeld, M., Nascimento, P. R., Baesler, K., Knuever, J., Spoerri, L., Schaider, H., Weninger, W. and Haass, N. K. (2016). Rose Bengal melanoma therapy - phototoxicity versus intrinsic cytotoxicity. Asia-Pacific Combined Dermatology Research Conference 2016, Noosa, QLD Australia, 25–28 August 2016. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. |
|
2016 Conference Publication Can melanoma treatment be guided by a panel of predictive and prognostic microRNA biomarkers?Stark, M., Gray, E., Ziman, M., Soyer, H. P. and Schaider, H. (2016). Can melanoma treatment be guided by a panel of predictive and prognostic microRNA biomarkers?. 16th World Congress on Cancers of the Skin , Vienna, Austria, 31 August - 3 September 2016. Philadelphia, PA United States: Lippincott Williams & Wilkins. |
|
2016 Conference Publication Global histone modifications define early stress induced drug tolerance in cancerAl Emran, Abdullah, Menon, Dinoop Ravindran, Soyer, Peter, Gabrielli, Brian, Sturm, Rick, Herlyn, Meenhard and Schaider, Helmut (2016). Global histone modifications define early stress induced drug tolerance in cancer. American-Association-for-Cancer-Research (AACR) Special Conference on Chromatin and Epigenetics in Cancer, Atlanta, GA, United States, 24-27 September 2015. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.CHROMEPI15-B34 |
|
2016 Conference Publication Combination of sorafenib with aspirin synergistically target mutant NRAS melanomaMenon, D. R., Hammerlindl, H., Emran, A., Thakkar, D., Soyer, H. P., Herlyn, M., Krepler, C. and Schaider, H. (2016). Combination of sorafenib with aspirin synergistically target mutant NRAS melanoma. Asia‐Pacific Combined Dermatology Research Conference 2016, Noosa, QLD Australia, 25–28 August 2016. Richmond, VIC Australia: Wiley-Blackwell. |
|
2016 Conference Publication Identification of unique molecular signatures of differentially cycling tumour cell subpopulations in a 3D melanoma modelAhmed, F., Tonnessen, C., Spoerri, L., Daignault, S., Stark, M., Schaider, H., Hill, M. and Haass, N. (2016). Identification of unique molecular signatures of differentially cycling tumour cell subpopulations in a 3D melanoma model. Asia-Pacific Combined Dermatology Research Conference 2016, Noosa, QLD Australia, 25–28 August 2016. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/ajd.12584 |
|
2016 Conference Publication Stress induced multi-drug tolerance precedes acquired drug resistance in melanomaSchaider, H., Menon, D. R., Emran, A., Gabrielli, B., Haass, N., Somasundaram, R. and Herlyn, M. (2016). Stress induced multi-drug tolerance precedes acquired drug resistance in melanoma. 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, Barcelona Spain, 18-21 November 2014. Richmond, VIC Australia: Wiley-Blackwell . |
|
2016 Conference Publication Epigenetic remodelling of H3K9Me3 leads to early stress induced drug tolerance in cancerEmran, A. A., Menon, D. R., Marzese, D., Hammerlindl, H., Brafford, P., Stark, M., Huang, S., Hammerlindl, S., Gupta, D., Soyer, P., Sturm, R., Hoon, D., Gabrielli, B., Herlyn, M. and Schaider, H. (2016). Epigenetic remodelling of H3K9Me3 leads to early stress induced drug tolerance in cancer. Asia‐Pacific Combined Dermatology Research Conference 2016, Noosa, QLD Australia, 25–28 August 2016. Richmond, VIC Australia: Wiley-Blackwell. |
|
2016 Conference Publication Notch4 mediated MET-like transition involves crosstalk with non-canonical WNT signalling in melanomaHammerlindl, H., Rad, E. B., Menon, D. R., Hafner, C., Herlyn, M. and Schaider, H. (2016). Notch4 mediated MET-like transition involves crosstalk with non-canonical WNT signalling in melanoma. Asia‐Pacific Combined Dermatology Research Conference 2016, Noosa, QLD Australia, 25–28 August 2016. Richmond, VIC Australia: Wiley-Blackwell. |
|
2015 Conference Publication An early innate stress response precedes acquired drug resistance in melanomaMenon, Dinoop Ravindran, Das, Suman, Krepler, Clemens, Vultur, Adina, Zhang, Gao, Haass, Nikolas, Soyer, Peter H., Gabrielli, Brian, Somasundaram, Rajasekharan, Hoefler, Gerald, Herlyn, Meenhard and Schaider, Helmut (2015). An early innate stress response precedes acquired drug resistance in melanoma. 106th Annual Meeting of the American-Association-for-Cancer-Research (AACR), Philadelphia Pa United States, April 18-22, 2015. Philadelphia, PA United States: American Association for Cancer Research. doi: 10.1158/1538-7445.AM2015-2684 |
|
2015 Conference Publication Molecular profiles of reticular and globular naevus patterns: a pilot studyOng, N., Duffy, D., Leikvold, A., Lee, K., Jagirdar, K., Lin, Lynlee L., Yamada, M., Sturm, R. A., Prow, T. W., Schaider, H. and Soyer, H. P. (2015). Molecular profiles of reticular and globular naevus patterns: a pilot study. 48th Annual Scientific Meeting of the Australasian College of Dermatologists, Adelaide SA, Australia, 16 May 2015. Richmond, VIC Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/ajd.12337 |
|
2015 Conference Publication Feasibility of genotyping melanocytic lesions by microsamplingTan, Jean-Marie, Lin, Lynlee L., Lambie, Duncan, Ong, Natalie, Flewell-Smith, Ross, Jagirdar, Kasturee, Schaider, Helmut, Sturm, Richard A., Prow, Tarl W. and Soyer, H. Peter (2015). Feasibility of genotyping melanocytic lesions by microsampling. 73rd Annual Meeting of the American Academy of Dermatology, San Francisco, California, 20–24 March 2015. Philadelphia, PA United States: Mosby. |
|
2015 Conference Publication The Chemokine Receptor Profile As Distinctive Criterion Between Normal B-Cell Subsets and As Potential Discriminative Marker to Identify the Cell of Origin in Patients with Chronic Lymphocytic Leukemia and Richter SyndromeTroppan, Katharina, Wenzl, Kerstin, Neumeister, Peter, Beham-Schmid, Christine, Przekopowitz, Martina, Greinix, Hildegard T., Schaider, Helmut and Deutsch, Alexander J. A. (2015). The Chemokine Receptor Profile As Distinctive Criterion Between Normal B-Cell Subsets and As Potential Discriminative Marker to Identify the Cell of Origin in Patients with Chronic Lymphocytic Leukemia and Richter Syndrome. 55th Annual Meeting and Exposition of the American-Society-of-Hematology, New Orleans LA, United States, 7-10 December 2013. Washington, DC United States: American Society of Hematology. |
|
2015 Conference Publication Notch4 drives mesenchymal-epithelial transition in melanomaRad, E. Bonyadi, Hammerlindl, H., Wels, C., Menon, D., Soyer, H. P., Bergler, H. and Schaider, H. (2015). Notch4 drives mesenchymal-epithelial transition in melanoma. 42nd Annual Meeting of the Arbeitsgemeinschaft Dermatologische Forschung (ADF), Ulm, Germany, 05-07 March 2015. Chichester, West Sussex, United Kingdom: Wiley-Blackwell Publishing. doi: 10.1111/exd.12623 |
|
2014 Conference Publication A stress induced early innate response causes multi-drug tolerance in melanomaMenon, D. R., Das, S., Krepler, C., Vultur, A., Rinner, B., Schauer, S., Kashofer, K., Wagner, K., Zhang, G., Rad, E. Bonyadi, Soyer, H. P., Gabrielli, B., Somasundaram, R., Hoefler, G., Herlyn, M. and Schaider, H. (2014). A stress induced early innate response causes multi-drug tolerance in melanoma. 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, Barcelona Spain, Nov 18-21, 2014. OXFORD: ELSEVIER SCI LTD. doi: 10.1016/S0959-8049(14)70219-9 |
|
2014 Conference Publication Human lactoferricin derivatives as new targeted weapons in cancer therapyRiedl, Sabrina, Rinner, Beate, Schaider, Helmut, Lohner, Karl and Zweytick, Dagmar (2014). Human lactoferricin derivatives as new targeted weapons in cancer therapy. 58th Annual Meeting of the Biophysical-Society, San Francisco United States, Feb 15-19, 2014. St. Louis, United States: Cell Press. doi: 10.1016/j.bpj.2013.11.554 |
